Max Healthcare Shares Under Pressure? JM Financial Assigns ‘REDUCE’ Rating; Check Target Price and Key Reason


Posted on 18th Aug 2026 04:03 pm by rohit kumar

Max Healthcare Institute has reported growth in revenue and profitability for the first quarter of financial year 2027 (Q1FY27). However, brokerage firm JM Financial has adopted a cautious stance on the stock, citing concerns over growth momentum.

 

The brokerage has assigned a ‘REDUCE’ rating to Max Healthcare, with the company's performance reportedly falling short of expectations in some key areas.

 

Did you know?Explore Trending and Topic pages for more stories like this.

Max Healthcare Q1FY27 Results: Revenue and EBITDA Rise 15%

 

According to JM Financial's report, Max Healthcare's revenue and EBITDA increased 15% year-on-year in Q1FY27.

 

The company's EBITDA margin remained broadly stable at 24.6%.

 

The hospital business benefited from improved operating metrics, with bed occupancy increasing 10% and ARPOB (Average Revenue Per Occupied Bed) rising 5%.

 

Despite these positive numbers, JM Financial believes the overall growth trajectory remains below expectations.

 

Why Did JM Financial Give a ‘REDUCE’ Rating?

 

The brokerage has highlighted two major concerns that could weigh on Max Healthcare's future growth.

 

1. Oncology Drug Prices Impact Revenue Mix

 

One of the key concerns relates to the oncology business.

 

According to the report, the discontinuation of certain chemotherapy drugs has affected the company's oncology revenue contribution. The share of oncology in inpatient revenue has declined from 26% to 22%.

 

Since oncology is an important component of hospital revenue, the change in the revenue mix could affect growth expectations going forward.

 

2. Delay in Adding New Beds

 

The second major concern is the slower pace of capacity expansion.

 

Max Healthcare has been adding new beds as part of its expansion strategy, but the pace of new-bed additions has reportedly been slower than expected.

 

A delay in expanding capacity could limit the company's ability to sustain higher revenue growth over the longer term.

 

Max Healthcare Stock: What Investors Should Watch

 

The Q1FY27 results show that Max Healthcare continues to deliver growth, particularly through improved occupancy and higher revenue per occupied bed.

 

However, investors will need to monitor:

 

The recovery of oncology-related revenue.

The pace of new-bed additions.

Occupancy levels across the hospital network.

ARPOB growth.

EBITDA margins and profitability.

The company's ability to meet future expansion targets.

Max Healthcare Share News: Key Takeaway

 

While Max Healthcare delivered 15% YoY growth in both revenue and EBITDA in Q1FY27, JM Financial remains cautious because growth has not fully met expectations.

 

The declining contribution from oncology revenue and delays in capacity expansion are the two key concerns highlighted by the brokerage. Investors should therefore consider these factors alongside the company's financial performance before making any investment decision.

1 Like 0 Dislike
Previous news Next news
Other news

LEAP India IPO Listing: Shares Make Tepid Debut, List at Over 4% Premium to Issue Price

KKR-backed LEAP India made a modest debut on the stock exchanges on Thursday, August 14, with sha

Asian Games 2026 Day 1: India Wins Two Silver Medals in Shooting, Assured of MMA Medal

India opened its medal campaign at the 20th Asian Games in Aichi-Nagoya with two silver medals in

IPO Subscription Hits 18x, GMP Jumps Sharply: Check Why Investors Are Watching It

The Adroit Industries IPO has attracted strong investor interest on its final day of bidding, wit

National Sports Awards 2025: 17 Athletes Named for Arjuna Award; Tejaswin Shankar, Divya Deshmukh Among Winners

The Ministry of Youth Affairs and Sports has announced the National Sports Awards 2025, recognizi

Asian Games 2026: India-Pakistan Final Possible as Both Teams Reach Men’s Cricket Semi-Finals After Rain Washouts

An India-Pakistan cricket final could be on the cards at the Aichi-Nagoya Asian Games after both

Samsung 17-Inch Foldable Tablet Could Fold Down to 8 Inches: What We Know

Samsung is reportedly exploring a new category of foldable devices beyond smartphones, with a mas

Sanju Samson on India’s Defeat: Tilak Varma’s Wicket Changed the Game; Arshdeep Injury Update

India wicketkeeper-batter Sanju Samson has identified Tilak Varma’s dismissal as the turnin

IPOs This Week: HD Fire Protect, Fusion CX Among 5 Issues Targeting ₹1,600 Crore

India’s primary market is set for a busy week, with five IPOs scheduled across the mainboar

PM Modi Meets Asian Games 2026 Medal Winners: Says Athletes’ Success Is India’s Success

Prime Minister Narendra Modi met India’s medal-winning athletes from the Asian Games 2026 a

Paytm, MobiKwik Stocks Surge Up to 7% on UPI MDR: Why Brokerages Expect a Revenue Boost

India’s new UPI Merchant Discount Rate (MDR) framework has triggered fresh optimism across

Sign up to write
Sign up now if you have flare of writing..
Login   |   Register
Follow Us
Indyaspeak @ Facebook Indyaspeak @ Twitter Indyaspeak @ Pinterest RSS



Play Free Quiz and Win Cash